Upload File

fda: the full method airbus pdubois fda-s… · granted by the delivery of this document or the...

  • Home
  • Documents
  • FDA: the full method AIRBUS PDubois FDA-S… · granted by the delivery of this document or the disclosure of its content. This document shall not be reproduced or disclosed to a
18
DOWNLOADING Lima FDA Seminar Presented by Paul DUBOIS AIRBUS - Airline SMS & FDA Assistance

Upload: others

Post on 11-Jul-2020

0 views

Category:

Documents


0 download

Report

TRANSCRIPT

Page 1: FDA: the full method AIRBUS PDubois FDA-S… · granted by the delivery of this document or the disclosure of its content. This document shall not be reproduced or disclosed to a

DOWNLOADING

Lima FDA Seminar Presented by Paul DUBOIS

AIRBUS - Airline SMS & FDA Assistance

Page 2: FDA: the full method AIRBUS PDubois FDA-S… · granted by the delivery of this document or the disclosure of its content. This document shall not be reproduced or disclosed to a

© AIRBUS S.A.S. All rights reserved. Confidential and proprietary document.

Downloading - How to collect the Data?

Page 2

Recording Downloading Processing Analysis

Page 3: FDA: the full method AIRBUS PDubois FDA-S… · granted by the delivery of this document or the disclosure of its content. This document shall not be reproduced or disclosed to a

© AIRBUS S.A.S. All rights reserved. Confidential and proprietary document.

Page 3

Data Data Acquisition & Monitoring Units

Recording Units A/C Systems

Downloading - How to collect the Data?

Page 4: FDA: the full method AIRBUS PDubois FDA-S… · granted by the delivery of this document or the disclosure of its content. This document shall not be reproduced or disclosed to a

© AIRBUS S.A.S. All rights reserved. Confidential and proprietary document.

Page 4

Media Data Acquisition & Monitoring Units

Recording Units A/C Systems

Downloading - How to collect the Data?

Page 5: FDA: the full method AIRBUS PDubois FDA-S… · granted by the delivery of this document or the disclosure of its content. This document shall not be reproduced or disclosed to a

© AIRBUS S.A.S. All rights reserved. Confidential and proprietary document.

Page 5

Media Data Acquisition & Monitoring Units

Recording Units A/C Systems

Downloading - How to collect the Data?

Page 6: FDA: the full method AIRBUS PDubois FDA-S… · granted by the delivery of this document or the disclosure of its content. This document shall not be reproduced or disclosed to a

© AIRBUS S.A.S. All rights reserved. Confidential and proprietary document.

Page 6

Downloading - How to collect the Data?

Page 7: FDA: the full method AIRBUS PDubois FDA-S… · granted by the delivery of this document or the disclosure of its content. This document shall not be reproduced or disclosed to a

© AIRBUS S.A.S. All rights reserved. Confidential and proprietary document.

Page 7

Automatic wireless transfer of the recorded data when the aircraft is on ground shortly after landing via cellular/ PCS phone communication means and via internet network up to the ground base station computer for data processing. A procedure to recover the data in case of a failure of the system should be defined.

: Wireless GroundLink® system

Downloading - How to collect the Data?

Page 8: FDA: the full method AIRBUS PDubois FDA-S… · granted by the delivery of this document or the disclosure of its content. This document shall not be reproduced or disclosed to a

© AIRBUS S.A.S. All rights reserved. Confidential and proprietary document.

Page 8

A policy to recover the data has to be put in place whithin the maintenance and/or flight safety department taking into account the recording capacity of each media. The procedure should also consider the limited read/write cycle of these media.

Downloading - How to collect the Data?

Page 9: FDA: the full method AIRBUS PDubois FDA-S… · granted by the delivery of this document or the disclosure of its content. This document shall not be reproduced or disclosed to a

© AIRBUS S.A.S. All rights reserved. Confidential and proprietary document.

Page 9

Downloading - How to collect the Data?

Page 10: FDA: the full method AIRBUS PDubois FDA-S… · granted by the delivery of this document or the disclosure of its content. This document shall not be reproduced or disclosed to a

© AIRBUS S.A.S. All rights reserved. Confidential and proprietary document.

Page 10

OK

Downloading - How to collect the Data?

Page 11: FDA: the full method AIRBUS PDubois FDA-S… · granted by the delivery of this document or the disclosure of its content. This document shall not be reproduced or disclosed to a

© AIRBUS S.A.S. All rights reserved. Confidential and proprietary document.

Page 11

Request for Remedial Action

Downloading - How to collect the Data?

Page 12: FDA: the full method AIRBUS PDubois FDA-S… · granted by the delivery of this document or the disclosure of its content. This document shall not be reproduced or disclosed to a

© AIRBUS S.A.S. All rights reserved. Confidential and proprietary document.

Page 12

Downloading - How to collect the Data?

Page 13: FDA: the full method AIRBUS PDubois FDA-S… · granted by the delivery of this document or the disclosure of its content. This document shall not be reproduced or disclosed to a

© AIRBUS S.A.S. All rights reserved. Confidential and proprietary document.

Page 13

Maintenance Action

Downloading - How to collect the Data?

Page 14: FDA: the full method AIRBUS PDubois FDA-S… · granted by the delivery of this document or the disclosure of its content. This document shall not be reproduced or disclosed to a

© AIRBUS S.A.S. All rights reserved. Confidential and proprietary document.

The data recovery process should be secured through a useful and understood procedure in order to minimize:

The amount of lost data

The waiting period before processing

Page 14

Downloading - BEST PRACTICES

Page 15: FDA: the full method AIRBUS PDubois FDA-S… · granted by the delivery of this document or the disclosure of its content. This document shall not be reproduced or disclosed to a

© AIRBUS S.A.S. All rights reserved. Confidential and proprietary document.

A technical log should be established with:

Disc or Card identification (date in/out , aircraft MSN…)

The number of retrieved flights

The status of cards or disks

And don’t forget to format them before putting them

back on board

Page 15

Downloading - BEST PRACTICES

Page 16: FDA: the full method AIRBUS PDubois FDA-S… · granted by the delivery of this document or the disclosure of its content. This document shall not be reproduced or disclosed to a

© AIRBUS S.A.S. All rights reserved. Confidential and proprietary document.

Page 16

One of the global indicator of the overall recorder Download Process quality is to compare the number of recorded flights to the number of operated flights per month.

Downloading - BEST PRACTICES

Page 17: FDA: the full method AIRBUS PDubois FDA-S… · granted by the delivery of this document or the disclosure of its content. This document shall not be reproduced or disclosed to a

© AIRBUS S.A.S. All rights reserved. Confidential and proprietary document.

Page 17

For Data Recovery reliability

Automated wireless downloading system

It guarantees a high rate of downloaded flights by avoiding overloaded memories and thus partial loss of flight data

Less disk or card technical problems No delay

so analysis process shortened and efficiency improved Less manpower

Downloading - BEST PRACTICES

Page 18: FDA: the full method AIRBUS PDubois FDA-S… · granted by the delivery of this document or the disclosure of its content. This document shall not be reproduced or disclosed to a

© AIRBUS S.A.S. All rights reserved. Confidential and proprietary document.

This document and all information contained herein is the sole property of AIRBUS S.A.S. No intellectual property rights are granted by the delivery of this document or the disclosure of its content. This document shall not be reproduced or disclosed to a third party without the express written consent of AIRBUS S.A.S. This document and its content shall not be used for any purpose other than that for which it is supplied. The statements made herein do not constitute an offer. They are based on the mentioned assumptions and are expressed in good faith. Where the supporting grounds for these statements are not shown, AIRBUS S.A.S. will be pleased to explain the basis thereof.


FDA Guidance Document Prosthetic Knee Ligament

FDA Briefing Document: Arthritis Advisory Committee ...€¦ · BLA 761024 AAC Brief ABP 501, a proposed biosimilar to Humira 1 . FDA Briefing Document . Arthritis Advisory Committee

FDA Briefing Document Oncologic Drugs Advisory Committee

US FDA Process Validation Guidance...US FDA The terms IQ, OQ and PQ are not directly referenced in the US FDA Guidance document but if appropriate remain relevant • Manufacturers

FDA Guidance Document on Medical Device - MRI Interaction - 2016-0114

Service Management - Verizon Wireless · Service Management User Guide Proprietary & Confidential Statement: This document and the information disclosed within, including the document

FDA Review Document - FDAnews

FDA Briefing Document Gastrointestinal Drug Advisory ... · FDA Briefing Document . Gastrointestinal Drug Advisory Committee Meeting . October 18, 2018 . The committee will discuss

Gadolinium-Based Contrast Agents & Nephrogenic Systemic Fibrosis FDA Briefing Document

FDA Briefing Document Pharmacy Compounding …...FDA Briefing Document Page 4 June 23, 2016 FDA is considering those substances nominated for inclusion on the list of bulk drug substances

Adocuments.worldbank.org/curated/en/969751468332343688/... · Web viewly disclosed, the front of the document should include the following language: "This document is being made publicly

FDA Guidance Document for GLPs

FDA Briefing Document Arthritis Advisory Committee Meeting .../media/Supporting Documents/T… · FDA Briefing Document . Arthritis Advisory Committee Meeting . February 09, ... (see

FDA Briefing Document Oncologic Drugs Advisory Committee ... · In this document, FDA generally refers to Sandoz’ proposed product by the Sandoz descriptor “EP2006” because

FDA Briefing Document Oncologic Drugs Advisory Committee ...€¦ · FDA Briefing Document . Oncologic Drugs Advisory Committee Meeting . April 12, 2016 . NDA 208542 . Rociletinib

How to Document Samples for FDA Detained Product

FDA Briefing Document JOINT MEETING OF THE ... · fda briefing document . joint meeting of the gastrointestinal drugs advisory committee and drug safety and risk management advisory

Overview of FDA Guidance Document Developed by Dose of Digital

Document Control in FDA Regulated Environments - When and how to automate

EXPAREL - fda.gov · EXPAREL Briefing Document: 14-15 February 2018 FDA Advisory Committee Meeting. FDA ADVISORY COMMITTEE MEETING BRIEFING DOCUMENT . EXPAREL® (bupivacaine liposome

FDA Briefing Document · FDA Briefing Document Peripheral and Central Nervous System Drugs. Advisory Committee Meeting January 22, 2016 NDA 206488 Eteplirsen

FDA Briefing Document Committee Meeting February 09, · PDF fileAAC Brief BLA 125544 CT-P13, a proposed biosimilar to Remicade. FDA. Briefing Document Arthritis Advisory Committee

Responsive Document - CREW: FDA: Regarding Rep. Jim Renacci: 7/11/2012 - Doc 3

Preparing Your Aseptic Processing Facility for an FDA ... · PDF filePreparing Your Aseptic Processing Facility for an FDA Inspection . ... document the general principles, ... Technique

Recommended Changes to Withdrawn FDA Draft Stratified Sampling Guidance Document · Recommended Changes to Withdrawn FDA Draft Stratified Sampling Guidance Document ISPE Blend and

FDA Briefing Document, Psychopharmacologic Drugs Advisory Committee … FDA Briefing Document Psychopharmacologic Drugs Advisory Committee (PDAC) Meeting February 3, 2016 Topic: Cognitive

FDA Briefing Document Bone, Reproductive and Urologic Drugs

FDA Briefing Document: Vaccines and Related Biological Products ... · FDA Briefing Document . Vaccines and Related Biological Products Advisory Committee Meeting . September 19,

FDA Briefing Document: Vaccines and Related Biological ...FDA Briefing Document . Vaccines and Related Biological Products Advisory Committee Meeting . September 19, 2012 . Cell Lines

FDA Briefing Document 14, 2020 of the Tobacco

FDA Briefing Document May 4,2004 Oncologic Drugs Advisory

RELIABILITY OF DISCLOSED INTERNAL CONTROL WEAKNESS AND ... · RELIABILITY OF DISCLOSED INTERNAL CONTROL WEAKNESS AND CHANGES IN ... I first document that in the pre-adoption ... Type

FDA ADVISORY COMMITTEE BRIEFING DOCUMENT/media/Supporting... · Xtampza ER Briefing Document: September 11, 2015 FDA Advisory Committee Meeting Page 1 of 93 . FDA ADVISORY COMMITTEE

FDA BRIEFING DOCUMENT ANTI-INFECTIVE DRUGS ADVISORY .../media/Supporting... · 1 FDA BRIEFING DOCUMENT . ANTI-INFECTIVE DRUGS ADVISORY COMMITTEE MEETING . JANUARY 22, 2015 . NDA 207-501:

The attached document is hereby disclosed for the sole · The attached document is hereby disclosed for the sole ... distribution of this document, ... are fully dissolved into an